![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, August 21, 2020 4:09:58 PM
I find nothing even remotely close to the statements in the 8/10 Letter:
* We now have signed long term contracts with, and received initial stocking orders and cash deposits from, three major companies
* These initial orders total more than 120,000 ActiPatch devices
* These three companies will be selling our devices into the United States over-the-counter (OTC) consumer health retail market
* We also have a signed agreement with a commercial firm that is in the process of recruiting and training up to 400 independent sales representatives who will actively sell our RecoveryRx postoperative pain product line into doctors’ offices, wound clinics, nursing facilities, and hospitals
* In terms of international sales, we recently signed a licensing agreement with a major international company and are in the final stages of signing an agreement with another large international company
https://www.globenewswire.com/news-release/2020/08/10/2075545/0/en/BioElectronics-Chairman-Outlines-New-Direction-for-Company.html
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM